Ana Martín-Pellicer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Martín-Pellicer has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alba López-Fernández
Bioprocessing for Advanced Cell Therapies (BACT) Group, Cell Therapy Service, Blood and Tissue Bank (BST), 08005 Barcelona, Catalonia, Spain
1 shared publication - Alexander Agrifoglio
Department of Intensive Care Medicine, Hospital Universitario La Paz, Paseo de la Castellana 264, 28046 Madrid, Spain
1 shared publication - Belén Civantos-Martín
Intensive Care Unit, La Paz University Hospital, Madrid, Spain. IdiPAZ Hospital La Paz Institute for Health Research, La Paz University Hospital , Madrid
1 shared publication - Claudia Díaz-Alvariño
Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain
1 shared publication - Henar Casero
Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain
1 shared publication - Irene Seises
Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 29 June 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-7
The role of routine FIBERoptic bronchoscopy monitoring during percutaneous dilatational TRACHeostomy (FIBERTRACH): a study protocol for a randomized, controlled clinical trial
Background: Tracheostomy is one of the most frequent techniques in intensive care units (ICU). Fiberoptic bronchoscopy (FB) is a safety measure when performing a percutaneous dilatational tracheostomy (PDT), but the controversy surrounding the routine use of FB as part of the procedure remains open. National surveys in some European countries showed that the use of FB is non-standardized. Retrospective studies have not shown a significant difference in complications between procedures performed with or without a bronchoscope. International guidelines have not been able to establish recommendations regarding the use of FB in PDT due to lack of evidence.Design: This is a multicenter (three centers at the time of publishing this paper) randomized controlled clinical trial to examine the safety of percutaneous tracheostomy using FB. We will include all consecutive adult patients admitted to the ICU in whom percutaneous tracheostomy for prolonged mechanical ventilation is indicated and with no exclusion criteria for using FB. Eligible patients will be randomly assigned to receive blind PDT or PDT under endoscopic guidance. All procedures will be performed by experienced intensivists in PDT and FB. A Data Safety and Monitoring Board (DSMB) will monitor the trial. The primary outcome is the incidence of perioperative complications.Discussion: FB is a safe technique when performing PDT although its use is not universally accepted in all ICUs as a routine practice. Should PDT be monitored routinely with endoscopic guidance? This study will assess the role of FB monitoring during PDT.Trial registration: ClinicalTrials.gov NCT04265625. Registered on February 11, 2020
- 29 June 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-7
Open AccessThe role of routine FIBERoptic bronchoscopy monitoring during percutaneous dilatational TRACHeostomy (FIBERTRACH): a study protocol for a randomized, controlled clinical trial
Background: Tracheostomy is one of the most frequent techniques in intensive care units (ICU). Fiberoptic bronchoscopy (FB) is a safety measure when performing a percutaneous dilatational tracheostomy (PDT), but the controversy surrounding the routine use of FB as part of the procedure remains open. National surveys in some European countries showed that the use of FB is non-standardized. Retrospective studies have not shown a significant difference in complications between procedures performed with or without a bronchoscope. International guidelines have not been able to establish recommendations regarding the use of FB in PDT due to lack of evidence.Design: This is a multicenter (three centers at the time of publishing this paper) randomized controlled clinical trial to examine the safety of percutaneous tracheostomy using FB. We will include all consecutive adult patients admitted to the ICU in whom percutaneous tracheostomy for prolonged mechanical ventilation is indicated and with no exclusion criteria for using FB. Eligible patients will be randomly assigned to receive blind PDT or PDT under endoscopic guidance. All procedures will be performed by experienced intensivists in PDT and FB. A Data Safety and Monitoring Board (DSMB) will monitor the trial. The primary outcome is the incidence of perioperative complications.Discussion: FB is a safe technique when performing PDT although its use is not universally accepted in all ICUs as a routine practice. Should PDT be monitored routinely with endoscopic guidance? This study will assess the role of FB monitoring during PDT.Trial registration: ClinicalTrials.gov NCT04265625. Registered on February 11, 2020